AdoRx Therapeutics Company
AdoRx Therapeutics is pursuing the discovery of new therapeutics for cancer based on modulation of the adenosine pathway.
Technology:
Small Molecules
Industry:
PharmTech
Headquarters:
Edinburgh, Edinburgh, City of, United Kingdom
Founded Date:
2017
Employees Number:
1-10
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Register and Claim Ownership